CYSTITIS ULCERATIVE

CYSTITIS ULCERATIVE was reported 67 times

CYSTITIS ULCERATIVE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Thyroid Hormone Synthesis Inhibitor [EPC] 1 0.0001
1 Progesterone [EPC] 1 0.0000
2 beta3-Adrenergic Agonist [EPC] 2 0.0000
3 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
4 Ester Local Anesthetic [EPC] 2 0.0000
5 Non-Standardized Chemical Allergen [EPC] 2 0.0000
6 Amide Local Anesthetic [EPC] 2 0.0000
7 Protease Inhibitor [EPC] 1 0.0000
8 Dietary Cholesterol Absorption Inhibitor [EPC] 2 0.0000
9 Copper-containing Intrauterine Device [EPC] 1 0.0000
10 Antiarrhythmic [EPC] 2 0.0000
11 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
12 Cytochrome P450 3A Inhibitor [EPC] 1 0.0000
13 Estrogen [EPC] 2 0.0000
14 Acetylcholine Release Inhibitor [EPC] 1 0.0000
15 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
16 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
17 Thalidomide Analog [EPC] 4 0.0000
18 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
19 Kinase Inhibitor [EPC] 4 0.0000
20 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
21 Angiotensin 2 Receptor Blocker [EPC] 2 0.0000
22 HMG-CoA Reductase Inhibitor [EPC] 2 0.0000
23 Alkylating Drug [EPC] 1 0.0000
24 Opioid Agonist [EPC] 1 0.0000
25 Platinum-based Drug [EPC] 1 0.0000
26 Factor Xa Inhibitor [EPC] 1 0.0000
27 Tumor Necrosis Factor Blocker [EPC] 3 0.0000
28 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
29 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
30 Loop Diuretic [EPC] 1 0.0000
31 Corticosteroid [EPC] 2 0.0000
32 Benzodiazepine [EPC] 1 0.0000